Evidence map›Paper›PMID 36878710›Full record

ArticleRNA (New York, N.Y.)2023

Translation reinitiation after uORFs does not fully protect mRNAs from nonsense-mediated decay.

Paul J Russell, Jacob A Slivka, Elaina P Boyle, Arthur H M Burghes, Michael G Kearse

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Evaluating the reliability of tools for mRNA annotation and IRES studies.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tiny but mighty: Diverse functions of uORFs that regulate gene expression.Computational and structural biotechnology journal · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Paul J RussellCellular, Molecular, and Biochemical Sciences Program, The Ohio State University, Columbus, Ohio 43210, USA.
Jacob A SlivkaDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, Ohio 43210, USA.
Elaina P BoyleDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, Ohio 43210, USA.
Arthur H M BurghesDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, Ohio 43210, USA.
Michael G KearseCellular, Molecular, and Biochemical Sciences Program, The Ohio State University, Columbus, Ohio 43210, USA michael.kearse@osumc.edu.
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Cellular, molecular, and biochemical sciences training grantT32GM141955 · NIGMS · OHIO STATE UNIVERSITY · PI Jane Elizabeth Jackman, JESSE J KWIEK · 2021 to 2026
$2.2M
Cellular, molecular, and biochemical sciences training grantT32GM086252 · NIGMS · OHIO STATE UNIVERSITY · PI JACKMAN, JANE ELIZABETH, MUSIER-FORSYTH, KARIN M · 2011 to 2020
$2.0M
Non-canonical mechanisms of translation initiation and regulationR35GM146924 · NIGMS · OHIO STATE UNIVERSITY · PI Michael G. Kearse · 2022 to 2026
$1.9M
Specialized regulation of non-AUG translationR00GM126064 · NIGMS · OHIO STATE UNIVERSITY · PI KEARSE, MICHAEL G · 2019 to 2021
$747k
NCI NIH HHS P30 CA016058NIGMS NIH HHS R00 GM126064NIGMS NIH HHS R35 GM146924NIGMS NIH HHS T32 GM086252NIGMS NIH HHS T32 GM141955
6 · The paper itself

Abstract

It is estimated that nearly 50% of mammalian transcripts contain at least one upstream open reading frame (uORF), which are typically one to two orders of magnitude smaller than the downstream main ORF. Most uORFs are thought to be inhibitory as they sequester the scanning ribosome, but in some cases allow for translation reinitiation. However, termination in the 5' UTR at the end of uORFs resembles premature termination that is normally sensed by the nonsense-mediated mRNA decay (NMD) pathway. Translation reinitiation has been proposed as a method for mRNAs to prevent NMD. Here, we test how uORF length influences translation reinitiation and mRNA stability in HeLa cells. Using custom 5' UTRs and uORF sequences, we show that reinitiation can occur on heterologous mRNA sequences, favors small uORFs, and is supported when initiation occurs with more initiation factors. After determining reporter mRNA half-lives in HeLa cells and mining available mRNA half-life data sets for cumulative predicted uORF length, we conclude that translation reinitiation after uORFs is not a robust method for mRNAs to prevent NMD. Together, these data suggest that the decision of whether NMD ensues after translating uORFs occurs before reinitiation in mammalian cells.

Indexed as

Nonsense Mediated mRNA DecayRibosomes5' Untranslated RegionsHeLa CellsHumansOpen Reading FramesProtein BiosynthesisRNA, Messenger5' Untranslated RegionsRNA, MessengereIFmRNA decayNMDribosometranslational control

Identifiers

PMID36878710
PMCPMC10187673
OpenAlexW4323348154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.